Furthermore, based on our results, SPRYD7 was observed to favor liver homing and tumor growth in vivo and to induce cell migration and invasion, which might also be associated with the high blood-vessel-formation capacity of cells overexpressing SPRYD7. This evidence concerns the gene SPRYD7 and neoplasm.